Porta, Chiara <br/><br/>
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.  [electronic resource] 

 -  Cancer research  07 2020 
 - 2874-2888 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-19-2843  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Cell Differentiation<br/>Cell Proliferation<br/>Colorectal Neoplasms--drug therapy<br/>Dinoprostone--pharmacology<br/>Humans<br/>Immune Tolerance<br/>Interferon-gamma--metabolism<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Monocytes--drug effects<br/>Myeloid-Derived Suppressor Cells--drug effects<br/>NF-kappa B p50 Subunit--genetics<br/>Nitric Oxide--metabolism<br/>Oxytocics--pharmacology<br/>Pancreatic Neoplasms--drug therapy<br/>Tumor Cells, Cultured